| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 237,70 | 238,60 | 20.02. | |
| 237,90 | 238,50 | 20.02. |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 330,00 | 45 | |||
| 320,00 | 50 | |||
| 302,60 | 15 | |||
| 293,00 | 36 | |||
| 285,00 | 15 | |||
| 238,70 | 32 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/esl.htm [/URL] | ||||
| 32 | 238,10 | |||
| 60 | 230,00 | |||
| 1 | 1,000 | |||
| 1.068 | 0,000 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 1.161 | 0,166 | 193 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 17:22:35 | 238,80 | 413 |
| 17:22:35 | 238,80 | 187 |
| 17:15:11 | 239,00 | 2 |
| 17:08:51 | 238,70 | 3 |
| 17:01:10 | 237,80 | 40 |
| 16:32:05 | 235,90 | 68 |
| 16:03:47 | 238,00 | 5 |
| 15:30:39 | 233,70 | 1 |
| 14:47:44 | 232,80 | 63 |
| 14:47:44 | 232,90 | 27 |
| 14:29:35 | 231,20 | 88 |
| 14:29:35 | 231,30 | 150 |
| 14:29:35 | 231,40 | 1.288 |
| 14:29:35 | 231,60 | 27 |
| 14:29:35 | 231,70 | 187 |
| 14:29:35 | 231,80 | 160 |
| 12:35:38 | 232,80 | 5 |
| 11:03:42 | 233,80 | 63 |
| 10:37:53 | 233,70 | 12 |
| 09:40:26 | 233,60 | 50 |
| Tagesumsatz Xetra | +4,20 +1,80 % | 2.993 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Son of EssilorLuxottica founder plans to buy siblings' Delfin stake, source says | 8 | Reuters | ||
| Do | Mark Zuckerberg vor Gericht gegrillt, seine Ray-Ban-Glassholes ebenso | 12 | WinFuture.de | ||
| Do | Meta-Smartwatch & Ray-Ban Display 2 sollen noch 2026 starten | 6 | Allround-PC.com | ||
| ESSILORLUXOTTICA Aktie jetzt für 0€ handeln | |||||
| Do | Bericht: Meta plant Smartwatch und Ray-Ban Display 2 noch für dieses Jahr | 22 | heise online | ||
| Do | Mark Zuckerberg and his Ray-Ban entourage have their day in court | 10 | The Verge |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Fr | Paxman AB: Paxman Announces Category III CPT Codes for Cryocompression Therapy to Prevent Chemotherapy-Induced Peripheral Neuropathy | GlobeNewswire (Europe) | Paxman, the global leader in cancer side effect management, today announced that the American Medical Association (AMA) CPT Editorial Panel has established three Category III CPT® codes describing the... ► Artikel lesen | |
| Fr | SRx Health Solutions, Inc.: SRx Health Solutions Increases Ownership of Opendoor Technologies by 30% and is Now Net Long Cryptocurrency Holdings | GlobeNewswire (Europe) | NORTH PALM BEACH, Fla., Feb. 20, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today announced increasing its ownership in the common stock of Opendoor... ► Artikel lesen | |
| Fr | BERENBERG stuft CARL ZEISS MEDITEC AG auf 'Hold' | dpa-AFX-Analyser | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Carl Zeiss Meditec von 35 auf 30 Euro gesenkt und die Einstufung auf "Hold" belassen. Nach dem im Januar zurückgezogenen Jahresausblick... ► Artikel lesen | |
| Fr | Sernova Biotherapeutics: Sernova Biotherapeutics Announces Warrant Amendments | Newsfile | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - February 20, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH0) ("the Company"), a leading regenerative medicine company... ► Artikel lesen | |
| Do | Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2025, Its 2026 Business Outlook, and Cash Dividend | PR Newswire | MECHANICSBURG, Pa., Feb. 19, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results... ► Artikel lesen |